From Skin to Bones: The Role of Injections in Infection Treatment

Infections, whether on the skin, in soft tissues, or deep within the bones, can range from mild inconveniences to life-threatening conditions. The right treatment not only alleviates symptoms but ensures the complete eradication of harmful pathogens. For severe infections, especially those resistant to oral medications, injectable antibiotics like Teicoplanin Injection IP play a pivotal role. Rouzel Pharma, with its advanced pharmaceutical solutions, introduces TICOVIS-200 and TICOVIS-400, the perfect allies in combating stubborn infections.

Understanding Infections: A Silent Threat

Infections are caused by harmful microorganisms such as bacteria, viruses, or fungi invading the body. While some infections are surface-level, like skin abscesses or cellulitis, others penetrate deeper, affecting bones (osteomyelitis) or internal organs. When these infections become severe, they often resist traditional oral antibiotics, requiring stronger, fast-acting solutions like injectable medications.

Why Injections?

Injectable antibiotics are highly effective for critical infections due to their:

1. Immediate Action: Bypassing the digestive system, injections deliver medication directly into the bloodstream.
2. High Bioavailability: They achieve optimal drug concentrations quickly, crucial for controlling infections.
3. Targeted Therapy: Ideal for treating infections caused by resistant bacteria.

The Power of Teicoplanin Injection IP

Teicoplanin, the active ingredient in TICOVIS-200 and TICOVIS-400, is a glycopeptide antibiotic specifically designed to treat severe bacterial infections. It is particularly effective against Gram-positive bacteria, including multi-resistant strains like MRSA (Methicillin-Resistant Staphylococcus Aureus).

Key Applications:

1. Skin and Soft Tissue Infections: Effective for cellulitis, abscesses, and infected wounds.
2. Bone and Joint Infections: Teicoplanin penetrates bone tissues, making it ideal for treating osteomyelitis.
3. Sepsis: Helps manage severe infections that have entered the bloodstream.
4. Endocarditis: An infection of the heart valves often caused by resistant bacteria.

Advantages of Teicoplanin:

• Once-Daily Dosing: Simplifies treatment regimens.
• Reduced Side Effects: Better tolerance compared to other glycopeptide antibiotics.
• Long Half-Life: Ensures sustained therapeutic levels in the body.

Rouzel Pharma’s Solutions: TICOVIS-200 and TICOVIS-400

Rouzel Pharma offers two potent formulations:

1. TICOVIS-200 (Teicoplanin Injection IP)
   • Strength: 200 mg/vial
   • Use: Ideal for moderate infections, including skin, soft tissue, and bloodstream infections.

2. TICOVIS-400 (Teicoplanin Injection IP)
   • Strength: 400 mg/vial
   • Use: Designed for severe cases, such as osteomyelitis, sepsis, and endocarditis.

Both products are manufactured under stringent quality standards to ensure safety, efficacy, and reliability.

Administering TICOVIS: What You Need to Know

• Dosage: The initial dose may require a loading phase, followed by maintenance doses tailored to the infection’s severity and patient’s weight.
• Route: Can be administered intravenously or intramuscularly, depending on medical recommendations.
• Duration: Treatment duration varies, with deep-seated infections often requiring extended therapy.

A Step Towards Health with Rouzel Pharma

Infections, especially those involving bones or resistant bacteria, demand precise, effective treatment. Rouzel Pharma’s TICOVIS-200 and TICOVIS-400 are powerful tools in modern medicine, designed to tackle even the toughest infections with precision.

If you or your patients require robust solutions for severe infections, trust Rouzel Pharma for high-quality, dependable treatment options. Let’s work together to ensure faster recoveries and healthier lives.

For more information on TICOVIS-200 and TICOVIS-400, contact Rouzel Pharma today!